Swiss Market Ends Moderately Lower
(RTTNews) - The Switzerland market ended on a weak note on Wednesday as investors largely stayed cautious and chose to lighten some commitments ahead of a slew of crucial economic data from the U.S.
The benchmark SMI, which stayed weak right through the day's session, settled with a loss of 98.41 points or 0.86% at 11,370.74, the day's low.
Shares of drugmaker Roche Holding ended down by 4.4% after the company reported a 6% drop in first-quarter sales.
UBS Group drifted down nearly 3%. Partners Group, Lindt Spruengli, Zurich Insurance Group, Julius Baer and Alcon lost 1.3 to 2%.
Swiss RE, Swisscom, Swatch Group and SIG Group ended lower by 0.9 to 1.1%. Lonza Group, Swiss Life Holding, Kuehne & Nagel and VAT Group lost 0.5 to 0.7%.
Logitech International, Sika, Givaudan, SGS, Holcim and Schindler Ps gained 0.4 to 0.9%. Novartis, Straumann Holding and ABB ended marginally up.
On the economic front, a report from UBS & CFA Society said the Swiss investors' sentiment index rose by 6.1 points from the previous month to 17.6 in April 2024, marking the highest reading since September 2021.
Canadian Dollar Eases Against Most Majors
Swiss Market Ends On Weak Note; Pharma Stocks Among Major Losers
European Markets Close Mostly Flat
Canadian Market Drifts Lower On Profit Taking
U.S. Consumer Sentiment Deteriorates Much More Than Expected In September
UK Economy Flatlines In July
Bay Street Likely To Open On Mixed Note
